Lupin Pharmaceuticals Inc. recalls Rifampin Capsules USP 300mg
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Subpotent Drug and Failed Impurities/Degradation Specifications
- Products
-
- Rifampin Capsules USP 300mg
- Company
- Lupin Pharmaceuticals Inc.
- Where it was sold
-
Product was distributed to 32 Wholesale/distributor accounts who further distributed the product to 156 distribution sites.
- Units affected
- 165,60 bottles
- About this recall
- Rifampin Capsules USP 300mg, 30-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States, Manufactured Lupin Limited, Aurangabad 431 210 INDIA, NDC 68180-659-06